Physician profile
Marque A Hunter
NPI 1568485258
$14,159.99
in general payments reported to CMS, 2019-2025
40 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,238 · 2020: $1,229 · 2021: $1,922 · 2022: $2,624 · 2023: $2,650 · 2024: $2,606 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,147.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,695.50 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,802.69 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Astrazeneca Pharmaceuticals LP | $1,543.68 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Grifols USA, LLC | $1,073.88 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $714.77 | 2022-2025 | Tezspire, Tavneos |
| Mylan Specialty L.P. | $584.20 | 2019-2024 | Yupelri |
| Baxter Healthcare | $456.29 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $439.11 | 2019-2025 | Dupixent |
| Genzyme Corporation | $427.76 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $390.71 | 2019-2024 | Opsumit |
| Janssen Pharmaceuticals, INC | $331.78 | 2019-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $294.95 | 2020-2024 | Glassia |
| Insmed, INC. | $235.01 | 2019-2025 | Arikayce, Brinsupri |
| Pfizer INC. | $195.98 | 2023-2025 | |
| Verona Pharma, INC. | $191.24 | 2025 | Ohtuvayre |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $190.72 | 2022 | |
| Abiomed | $187.62 | 2023-2024 | Impella |
| United Therapeutics Corporation | $162.76 | 2019-2025 | Tyvaso, Tyvaso |
| Inspire Medical Systems, INC. | $157.85 | 2019-2024 | Inspire |
| Merck Sharp & Dohme LLC | $137.92 | 2019-2024 | Keytruda, Winrevair |
| Abbvie INC. | $124.66 | 2021-2025 | |
| Genentech USA, INC. | $95.54 | 2019-2024 | Xolair |
| Mallinckrodt Hospital Products INC. | $93.54 | 2020-2025 | Terlivaz |
| Nabriva Therapeutics, Plc | $88.38 | 2021-2022 | |
| Medivance, INC. | $74.68 | 2021 | |
| Viatris Specialty LLC | $71.35 | 2025 | Yupelri |
| Gilead Sciences, INC. | $70.84 | 2021-2022 | |
| Philips North America LLC | $61.74 | 2021-2023 | |
| Inari Medical, INC. | $39.85 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shire North American Group INC | $33.26 | 2019 | |
| Inogen, INC. | $25.79 | 2022-2024 | |
| Axsome Therapeutics, INC. | $25.14 | 2025 | Sunosi |
| Ucb, INC. | $23.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.43 | 2020 | |
| Boston Scientific Corporation | $18.22 | 2023 | Exalt Model D |
| Advanced Respiratory, INC | $17.79 | 2021 | |
| Movair INC | $17.25 | 2025 | Luisa |
| Ani Pharmaceuticals, INC. | $14.06 | 2023 | Purified Cortrophin Gel |
| Sanofi-Aventis U.S. LLC | $13.68 | 2021 | |
| Allergan, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marque Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.